Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACB vs ACB + IPACK in ACL Reconstruction
NCT05316168Phase 3Unknown
- Sponsor
- Rothman Orthopaedics
- Start
- Sep 2023
- Primary completion
- Sep 2024
- Countries
- 1
01
Overview
Phase 3, randomised trial (2 arms), sponsored by Rothman Orthopaedics. Primary endpoints: Post operative pain management at 14 days and Post operative pain management 2 at 6 months. Status: unknown.
Beyond the preview
Go deeper on NCT05316168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05316168.